3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Recruiting
1
Completed
1
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Neoplasms
3
Smoking
1
Pulmonary Disease, Chronic Obstructive
1
Pancreatic Neoplasms
1
Neurologic Manifestations
1
Neoplasm Metastasis
1
Myelodysplastic Syndromes
1
Lymphoma, Follicular
1
Leukemia, Myeloid, Acute
1
Hyperlipoproteinemia Type II
1
Hematologic Neoplasms
1
Diabetes Mellitus
1
Dementia
1
Colorectal Neoplasms
1
Colitis, Ulcerative
1
Cardiovascular Diseases
1
Carcinoma, Hepatocellular
1
COVID-19
1
Interventions
Social Determinants of Health
2
Exercise
2
sofosbuvir-velpatasvir drug combination
1
ribociclib
1
palbociclib
1
ibrutinib
1
amlodipine, atorvastatin drug combination
1
acalabrutinib
1
abemaciclib
1
Standard of Care
1
Practice Guidelines as Topic
1
Positron-Emission Tomography
1
Methods
1
Interviews as Topic
1
Hematologic Tests
1
Fish Oils
1
Fatty Acids, Omega-3
1
Electrocardiography
1
Educational Status
1
Echocardiography
1
Early Intervention, Educational
1
Diet
1
Cholecalciferol
1
Chemoradiotherapy
1
Atorvastatin
1
ARQ531
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Active not recruiting
×
Cardiovascular Diseases
×
Atorvastatin
×
Clear all
NCT02099123
2024-11-21
STAREE
Monash University
Phase 4
Active not recruiting
9,971 enrolled